The adaptive immune response to porous regenerated keratin as a bone graft substitute in an ovine model.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
15 Dec 2020
Historique:
received: 09 07 2020
revised: 16 09 2020
accepted: 18 09 2020
pubmed: 28 9 2020
medline: 10 4 2021
entrez: 27 9 2020
Statut: ppublish

Résumé

Reconstituted keratin is a novel bone graft material when prepared as a rigid scaffold. Understanding the immunogenicity of this material is important to determine whether this substance is a viable surgical option. Previous studies have shown no innate immune system activation in response to reconstituted keratin implants. To examine antibody-mediated immune responses to reconstituted keratin implants, bone and blood samples were taken from twelve sheep with surgically created tibial defects containing such implants. RT-PCR was used to detect mRNA of the inflammatory marker SOCS 3 in local bony tissue, and a novel immunohistochemistry assay developed to detect antikeratin antibodies in serum. Two animals were sacrificed per time-point at weeks 1, 2, 4, 6, 8 and 12. Time points for serum analysis included baseline (pre-surgery) and all other time points; mRNA analysis examined samples from all time points. No upregulation in antikeratin antibodies or SOCS 3 mRNA was observed at any time point, indicating that reconstituted keratin implants do not trigger an adaptive immune response in vivo in an ovine model. These findings provide the platform for further development of keratin implants in other mammalian models to define its immunogenic profile and safety.

Identifiants

pubmed: 32980411
pii: S0141-8130(20)34491-3
doi: 10.1016/j.ijbiomac.2020.09.133
pii:
doi:

Substances chimiques

Bone Substitutes 0
Keratins 68238-35-7
Titanium D1JT611TNE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100-106

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Nil.

Auteurs

George J Dias (GJ)

Department of Anatomy, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand. Electronic address: george.dias@otago.ac.nz.

Niranjan Ramesh (N)

Department of Anatomy, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.

Laura Neilson (L)

Department of Anatomy, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.

Jon Cornwall (J)

Centre for Early Learning in Medicine, Otago Medical School, University of Otago, Dunedin 9054, New Zealand.

Robert J Kelly (RJ)

Lincoln Agritech Ltd., Lincoln, Christchurch 7640, New Zealand.

Greg M Anderson (GM)

Department of Anatomy, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH